These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15154833)

  • 61. Unravelling calcium-release channel gating: clues from a 'hot' disease.
    McCarthy TV; Mackrill JJ
    Biochem J; 2004 Jun; 380(Pt 2):e1-3. PubMed ID: 15154833
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease.
    Lyfenko AD; Goonasekera SA; Dirksen RT
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1256-66. PubMed ID: 15336973
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Personal recollections on the discovery of the ryanodine receptors of muscle.
    Fleischer S
    Biochem Biophys Res Commun; 2008 Apr; 369(1):195-207. PubMed ID: 18182155
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinct mechanisms for dysfunctions of mutated ryanodine receptor isoforms.
    Ogawa Y
    Biochem Biophys Res Commun; 2008 Apr; 369(1):208-12. PubMed ID: 18067858
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites.
    Laver DR
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):889-96. PubMed ID: 17645636
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ryanodine receptor channelopathies.
    Benkusky NA; Farrell EF; Valdivia HH
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1280-5. PubMed ID: 15336975
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Calcium-induced calcium release in skeletal muscle.
    Endo M
    Physiol Rev; 2009 Oct; 89(4):1153-76. PubMed ID: 19789379
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mutations in RYR1 in malignant hyperthermia and central core disease.
    Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P
    Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Current views of the molecular basis of the malignant hyperthermia syndrome.
    Heffron JJ; McCarthy TV
    Acta Anaesthesiol Belg; 1990; 41(2):73-8. PubMed ID: 2164742
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved.
    Avila G
    Cell Calcium; 2005 Feb; 37(2):121-7. PubMed ID: 15589992
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Control of muscle ryanodine receptor calcium release channels by proteins in the sarcoplasmic reticulum lumen.
    Beard NA; Wei L; Dulhunty AF
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):340-5. PubMed ID: 19278523
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Toward a molecular understanding of the structure-function of ryanodine receptor Ca2+ release channels: perspectives from recombinant expression systems.
    George CH; Yin CC; Lai FA
    Cell Biochem Biophys; 2005; 42(2):197-222. PubMed ID: 15858232
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ryanodine receptors as pharmacological targets for heart disease.
    Santonastasi M; Wehrens XH
    Acta Pharmacol Sin; 2007 Jul; 28(7):937-44. PubMed ID: 17588328
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Abnormal ryanodine receptor function in heart failure.
    Yano M; Yamamoto T; Ikemoto N; Matsuzaki M
    Pharmacol Ther; 2005 Sep; 107(3):377-91. PubMed ID: 15951021
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Defective Mg2+ regulation of RyR1 as a causal factor in malignant hyperthermia.
    Steele DS; Duke AM
    Arch Biochem Biophys; 2007 Feb; 458(1):57-64. PubMed ID: 16620769
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Redox regulation of cardiac calcium channels and transporters.
    Zima AV; Blatter LA
    Cardiovasc Res; 2006 Jul; 71(2):310-21. PubMed ID: 16581043
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Malignant hyperthermia may be due to a defect in a large Ca2+ release channel protein.
    Davies K
    Trends Genet; 1990 Jun; 6(6):171-2. PubMed ID: 2164719
    [No Abstract]   [Full Text] [Related]  

  • 78. Calcium transporters and their role in the development of neuronal disease and neuronal damage.
    Jaskova K; Pavlovicova M; Jurkovicova D
    Gen Physiol Biophys; 2012 Dec; 31(4):375-82. PubMed ID: 23255663
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dysregulation of the gain of CICR through ryanodine receptor1 (RyR1): the putative mechanism underlying malignant hyperthermia.
    Ogawa Y
    Adv Exp Med Biol; 2007; 592():287-94. PubMed ID: 17278373
    [No Abstract]   [Full Text] [Related]  

  • 80. Does the voltage-gated calcium channel alpha2delta-1 subunit play a dual function in skeletal muscle?
    Weiss N; Ivanova E
    J Physiol; 2008 Apr; 586(8):2035-7. PubMed ID: 18292126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.